HVEM expression is elevated in hepatocarcinoma [38], breast cancers [39], chronic lymphocytic leukemia (CLL) [13], and prostate cancer [28]. This evidence concerns the gene TNFRSF14 and B-cell chronic lymphocytic leukemia.